Skip to main content

This 10-session webinar series exploring access and inclusion in psychedelic treatment.


Kelly Sykes, PhD
Dr. Elizabeth Nielson
Alexander Camargo, PsyD

Guest Lecturers:

Cristie Strongman, Ed.M.
Joseph McCowan, PsyD
Rebecca Kronman, LCSW
Jeffrey Guss, MD
Dr. Ingmar Gorman
Tehseen Noorani


$100 10-Session Webinar Series, Includes 10 hours of CE credits | Fluence is approved by APA and NYSED to offer CE for Psychologists, Social Workers, and LMHCs
$12 - Any individual webinar, Includes 1 hour of CE credit

Course Description

Learning Objectives

At the end of this course, the participant will be able to:

  • Critique the implications of drug policy that impact marginalized populations’ access to psychedelic-assisted therapy.
  • Describe the mental health and policy barriers that perpetuate stigma and inequitable access to psychedelic-assisted therapy.
  • Explain the ways in which bias against individuals with mental illness are used to invalidate their perspectives, and how this relates to psychedelic-assisted therapy.
  • Analyze the role of ethnic and racial identity in psychedelic-assisted therapy research.
  • Analyze Intersection between research, policy, corporatization of psychedelics and its impact.
  • Describe current psychedelic decriminalization efforts in the US and their relationship to existing drug and religious use policies as well as its impact on indigenous communities.
  • Describe the role of gender within psychedelic therapist dyads, and between dyads and participants.
  • Demonstrate knowledge of unique aspects of PTSD in military populations that may impact their treatment with psychedelic-assisted therapy.
  • Explain the role and application of leading ethical guidelines for psychedelic-assisted therapy.
  • Demonstrate knowledge of controversies related to therapist  training, as well as therapist self-disclosure of personal experience with psychedelics.
purchase webinar bundle here
information for medical professionals and about CEs

Other Upcoming Courses

Thanks for signing up for our newsletter!
please enter a valid email address.